Find clinical trials for Pancreatic Cancer in Kansas City, KS
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Kansas City, KS, USA:
The goal of this clinical research study is to learn if Niraparib can help to control metastatic pancreatic cancer. The safety of t...
Phase 2
Kansas City, Kansas, United States and 5 other locations
Pancreatic cancer is a deadly disease and will be the second leading cause of cancer related death behind lung cancer...
Phase 1, Phase 2
Kansas City, Kansas, United States
ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...
Phase 1, Phase 2
Merriam, Kansas, United States and 27 other locations
open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...
Phase 1, Phase 2
Kansas City, Kansas, United States and 15 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Kansas City, Kansas, United States and 70 other locations
Researchers want to discover if the new drug "TG01" will work with participants' bodies to help their immune system attack any cancer cells ...
Phase 2
Kansas City, Missouri, United States and 4 other locations
cancer, gastroesophageal junction cancer (GEJ cancer) or pancreatic cancer. GEJ is where the tube that ...
Phase 1
Westwood, Kansas, United States and 42 other locations
This is a phase 1 first in human, dose escalation trial of GP-2250 administered in combination with gemcitabine in subjects with advanced pancreatic...
Phase 1
Fairway, Kansas, United States and 4 other locations
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON...
Phase 1, Phase 2
Westwood, Kansas, United States and 29 other locations
and efficacy of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers...
Phase 2
Kansas City, Kansas, United States and 65 other locations
Clinical trials
Research sites
Resources
Legal